Mirati Therapeutics, Inc. - News Releases

2019 2018 2017 2016 2015 2014 2013

11/03/2016

Mirati Therapeutics Reports Financial Results And Provides Business Update For The Third Quarter 2016

10/04/2016

Mirati Therapeutics Appoints Chris LeMasters To Role Of Executive Vice President And Chief Business Officer

9/29/2016

Mirati Therapeutics Announces Appointment Of Dr. Bruce L.A. Carter To Board Of Directors

8/04/2016

Mirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016

6/22/2016

Mirati Therapeutics Announces Change In Executive Leadership

6/05/2016

Mirati Therapeutics Provides Progress Update On Current Clinical Trials

6/01/2016

Mirati Therapeutics To Present At The Jefferies 2016 Healthcare Conference

5/19/2016

Mirati Therapeutics To Present Abstracts On Pipeline Programs At 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting

5/05/2016

Mirati Therapeutics Reports Financial Results And Business Update For The First Quarter 2016

3/24/2016

Mirati Therapeutics To Present Preclinical Data At 2016 American Association For Cancer Research Annual Meeting

3/23/2016

Mirati Therapeutics Announces Promotion Of Jamie A. Donadio To Chief Financial Officer

3/09/2016

Mirati Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Business Update

3/08/2016

Mirati Therapeutics To Present At The Barclays Global Healthcare Conference

1/08/2016

Mirati Therapeutics Appoints Marcy Graham Vice President, Investor Relations and Corporate Communications